Pharmaceutical law regulation of research, development, and marketing
editor-in-chief, Michael E. Clark.
- Arlington, Va Bureau of National Affairs c2007.
- xlvi, 853 p. 26 cm.
"American Bar Association, Health Law Section"
Includes bibliographical references and index.
Statutory and regulatory controls for drug development -- Key federal agencies regulating pharmaceuticals -- Federal regulation of advertising, promotion, and distribution practices -- Potential liability for drug companies, health care providers and insurers: off-label prescribing and internet advertising -- Federal regulation of clinical research -- Avoiding fraud and abuse penalties and sanctions -- Regulation of privacy under hipaa and other privacy laws -- Federal sentencing guidelines and compliance measures -- The FDA approval process for new drugs -- State regulatory schemes for pharmaceuticals and related issues -- Antitrust and intellectual law issues for pharmaceutical companies -- Securities law issues and disclosure considerations for pharmaceutical companies.
Pharmacy--Law and legislation--United States. Drug development--United States. Pharmaceutical Industry--United States. Drugs--Law and legislation--United States.